Organ Preservation Solutions Market
Organ Preservation Solutions Market Analysis, By Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Organ Type (Kidneys, Liver, Lungs, Heart), By End User (Organ Transplant Centers, Hospitals, Others) & Region - Global Market Insights 2027
Analysis of Organ Preservation Solutions market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Organ Preservation Solutions Market Outlook (2022 to 2027)
The global organ preservation solutions market currently accounts for a valuation of US$ 233 million and is anticipated to reach US$ 330 million by the end of 2027. Worldwide demand for organ preservation solutions is forecasted to accelerate at a CAGR of 7.2% from 2022 to 2027.
Demand for static cold storage techniques is predicted to increase at a higher CAGR of 7.5% through 2027. The kidneys, liver, lungs, pancreas, and heart are all preserved with these methods.
| Report Attributes | Details |
|---|---|
| Organ Preservation Solutions Market Size (2022) | US$ 233 Million |
| Projected Market Value (2027) | US$ 330 Million |
| Global Market Growth Rate (2022 to 2027) | 7.2% CAGR |
| Market Share of Static Cold Storage | 45% |
| Key Companies Profiled | BioLife Solutions, Inc.; Essential Pharmaceuticals, LLC; Lifeline Scientific, Inc.; Preservation Solutions, Inc.; XVIVO Perfusion AB; Teva Pharmaceutical Industries Ltd.; Bridge to Life Ltd.; Accord Healthcare; OrganOx Limited; ToleroTech, Inc.; Claris Injectables Limited; Paragonix Technologies Inc.; BioTime, Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Revenue Analysis of Organ Preservation Solutions (2017 to 2021) Vs. Market Projections (2022 to 2027)
“Increase in Organ Transplant Procedures Driving Demand for Organ Preservation Solutions”
According to Fact.MR, a market research and competitive intelligence provider, sales of organ preservation solutions are predicted to evolve at a CAGR of 7.2% from 2022 to 2027.
Since organs frequently collapse after being removed from the human body, organ preservation techniques are employed to safeguard organs before transplantation. Organ preservation techniques are used to keep organs safe for organ transplantation and research.
The rising rate of multi-organ failure, the ageing population, the increase in organ transplants and organ donors, and the expansion of programs to promote organ donation are the main factors driving market growth.
Rising number of persons who choose to donate their transplants and experimentation is also helping to fuel market growth. Additional elements, including increasing research and development and major advancements in the organ care systems, are predicted to have a significant impact on market growth as well.
Which Aspects are Shaping the Path of the Organ Preservation Solutions Market?
“Constant Advancements in Organ Preservation Techniques”
Market growth is significantly fueled by technological advancements. Key companies are currently working to develop cutting-edge protection and conservation methods to combat tissue edema and organ survival before transplantation.
A promising and efficient preservation method called persufflation enhances oxygenation, which enhances grafting during preservation, protection, and transplanting. To deliver better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures.
Several hospitals caring for patients who are brain dead and who might be potential donors will rise as a result of these infrastructure improvements.
One of the most frequent causes of death in ICUs is multiple organ failure, which is primarily brought on by sepsis. Acute renal failure is more common in the elderly due to age-related declines in renal plasma flow and glomerular filtration rate. Diabetes makes people more susceptible to both of these diseases and multiple organ failure. Geriatric patients are more likely to have illnesses, including TB and liver cirrhosis, which may necessitate organ transplantation.
- The Organ Procurement and Transplantation Network asserts that the increase in the number of elderly individuals undergoing organ transplants has a significant impact on the volume of organ transplantation procedures performed.
“Growing Prevalence of CKDs and Sepsis across Geographies”
Demand for organ preservation products is increased by conditions such as sepsis and chronic kidney diseases (CKDs). One of the most frequent causes of death in intensive care units is multiple organ failure, which is usually brought on by sepsis.
Sepsis is a diagnosis reaction to infection that, according to the World Health Organization (WHO), is frequently the last common pathway to mortality from many infectious illnesses globally. Sepsis incidence is difficult to determine on a global scale.
Many people don't realize they have CKDs until it is progressed since early-stage kidney infections frequently have no symptoms. Over time, kidney disease frequently gets worse, and it can cause renal failure as well as other health problems, including a heart attack or stroke. As a result, kidney failures have increased due to the rising prevalence of CKDs and sepsis, which is driving the organ preservation systems market.
To provide better healthcare services, governments all around the world are concentrating on bolstering their healthcare infrastructures. There will be more hospitals that handle more brain-dead people who might make good donors as a result of these infrastructure upgrades.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Challenges are Faced by Organ Preservation Solution Providers?
“High Cost of Organ Transplant Procedures and Available Alternatives”
The market for organ preservation solutions is suffering from a decrease in the number of organ donors available for transplants involving the kidney, liver, heart, and other organs.
The gap between supply and demand is growing as the number of organ donors drops, which could impede market expansion. Due to a lack of available organ donors, surgeons are increasingly turning to artificial organs. Additionally, the demand for organ transplants is impacted by a lack of reimbursement.
High cost of organ transplant procedures, the absence of suitable donors, and available alternatives to organ transplantation, such as the development of organs with the aid of stem cell treatments are hampering market growth.
How Can New Entrants Penetrate This Market?
“Start-ups Can Focus on Developing Innovative Organ Preservation Techniques”
New entrants are engaged in investing in research and development to create advanced products. New companies are working to develop innovative organ preservation methods that will extend their shelf lives while posing fewer hazards.
- OrganX Scientific, a start-up based in the U.S. seeks to transform organ transplantation by developing innovative novel preservation technologies. OrganX Scientific intends to commercialize its invention with active perfusion of blood through the organ while it is being transported and kept in settings that replicate the human body. This would lengthen an organ's ability to survive throughout shipment and guarantee that it stays in good shape.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Which Region Provides Optimistic Opportunities for Market Players?
“Better Reimbursement Policies in North America”
North America leads the organ preservation solutions market ascribed to many variables, including the increased demand for and use of organ transplantation as a result of the rise in chronic diseases and the rising requirement for preservation technologies to safeguard the viability of organs in ex-vivo settings.
The main drivers of market expansion in the region are the increasing acceptance of innovative medical technologies, better reimbursement policies, and rising investments in expanding healthcare infrastructure.
Country-wise Insights
Why is the U.S. a Major Market for Organ Preservation Solutions?
“Increase in Number of Patients of Alcoholic Fatty Liver Disease”
The U.S. market is anticipated to develop as a result of rising FDA approvals, the significant presence of manufacturers of organ preservation solutions, the rise in renal illnesses, and an increase in organ transplant procedures.
Due to the high number of organ transplants occurring in the country and the significant technological advancements made to perform these procedures, the market is predicted to grow quickly during the projected period.
The market has been fueled by an increase in the number of patients with alcoholic fatty liver diseases, an increase in demand for cutting-edge treatment options, and rising government investments in the development of organ preservation techniques.
How Will China Perform On a Global Scale?
“Growing Public Awareness about Organ Donation in China”
The organ preservation solutions market in China is expected to rise at a CAGR of 9% over the forecast period. The market in China is expanding as a result of factors such as an increasing geriatric population looking for better treatment options, growing public awareness about organ donation, and a supportive regulatory environment intended to enhance organ transplantation procedures.
Growing patient awareness, rising demand for lung preservation systems, rising prevalence of cardiovascular and renal disorders, and increased public and private investments are all expected to fuel market expansion.
Category-wise Insights
Which Technique Will Boost Organ Preservation Solutions Industry Growth?
“Growing Usage of Static Cold Storage for Organ Preservation”
Based on technique, the organ preservation solutions market is divided into normothermic machine perfusion, hypothermic machine perfusion, static cold storage, and others. Static cold storage accounts for 45% share of the global market due to its wide applicability.
The main purpose of static cold storage is kidney preservation. Due to the slowed kinetics of metabolic activities from the donor organ caused by the hypothermia induced in this approach, it is the most widely used and regarded as the gold standard method for organ preservation.
Additionally, it is projected that the existence of numerous market participants who provide static cold storage would foster segment expansion.
Why is Demand for Kidney Preservation Systems So High?
“Increasing Kidney Transplant Surgeries and Occurrences of Kidney Failure”
The organ preservation solutions market is segmented into liver, lungs, kidneys, heart, and others based on the organ type.
Kidney preservation systems are anticipated to contribute the largest amount of revenue due to a growth in kidney transplant surgeries and occurrences of kidney failure. It is also anticipated that several awareness initiatives highlighting the advantages of kidney transplantation will fuel market expansion.
For instance, the NHS started the "Advancing American Renal Health" initiative to improve the lives of patients with kidney diseases in the U.S.
Will Organ Transplant Centers Continue to Hold a Significant Market Share?
“Improved Medical Facilities in Organ Transplant Centers”
By end user, the organ preservation solutions market is categorized into organ transplant centers, hospitals, and specialty clinics.
The primary driver fueling the acceptance of organ transplant centers and accelerating market expansion is the rising number of transplant facilities throughout the world.
In several parts of the world, organ transplant centers offer liver and kidney preservation services. The improved medical facilities and rising success rate have made it a preferred option for transplant patients all around the world. Organ transplant centers are anticipated to continue to lead in organ preservation and transplantation over the coming years.
Competitive Landscape
Key players in the organ preservation solutions market are involved in reimbursement scenarios, the development of modern technologies, and the introduction of new products.
For instance :
- In 2021, the LIVERguard Donor Liver Preservation System was introduced by Paragonix Technologies in the U.S. and Europe. This tactic boosted Paragonix's global presence and broadened its range of products.
- In 2020, OrganoPlate Caco-2, an assay-ready product line was introduced by MIMETAS for organs-on-chips. 38 intestinal tubules were formed in this product while flowing against an extracellular matrix. The goal of this product's development was to make organs-on-chips technology accessible to everyone.
Organ Preservation Solutions Industry Research Segments
-
By Technique :
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Others
-
By Organ Type :
- Kidneys
- Liver
- Lungs
- Heart
- Others
-
By End User :
- Organ Transplant Centers
- Hospitals
- Specialty Clinics
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Risks and Trends Assessment
- 4. Market Background and Foundation Data Points
- 5. Global Market Demand (US$ Million) Analysis 2017 to 2021 and Forecast, 2022 to 2027
- 6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, By Technique
- 6.1. Static Cold Storage
- 6.2. Hypothermic Machine Perfusion
- 6.3. Normothermic Machine Perfusion
- 6.4. Others
- 7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Organ Type
- 7.1. Kidneys
- 7.2. Liver
- 7.3. Lungs
- 7.4. Heart
- 7.5. Others
- 8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by End User
- 8.1. Organ Transplant Centers
- 8.2. Hospitals
- 8.3. Specialty Clinics
- 9. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2027, by Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & Oceania
- 9.6. Middle East and Africa (MEA)
- 10. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 11. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 12. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 14. South Asia & Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 15. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2027
- 16. Market Structure Analysis
- 17. Competition Analysis
- 17.1. BioLife Solutions, Inc.
- 17.2. Essential Pharmaceuticals, LLC
- 17.3. Lifeline Scientific, Inc.
- 17.4. Preservation Solutions, Inc.
- 17.5. XVIVO Perfusion AB
- 17.6. Teva Pharmaceutical Industries Ltd.
- 17.7. Bridge to Life Ltd.
- 17.8. Accord Healthcare
- 17.9. OrganOx Limited
- 17.10. ToleroTech, Inc.
- 17.11. Claris Injectables Limited
- 17.12. Paragonix Technologies Inc.
- 17.13. BioTime, Inc.
- 18. Assumptions And Acronyms Used
- 19. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 02: Global Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 04: Global Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 05: Global Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 07: Global Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 08: Global Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2017 to 2021
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2022 to 2027
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2022 to 2027
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 16: North America Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 17: North America Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 19: North America Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 20: North America Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 22: North America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 23: North America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 28: Latin America Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 29: Latin America Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 31: Latin America Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 32: Latin America Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 34: Latin America Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 35: Latin America Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 40: Europe Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 41: Europe Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 43: Europe Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 44: Europe Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 46: Europe Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 47: Europe Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 52: East Asia Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 53: East Asia Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 55: East Asia Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 56: East Asia Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 58: East Asia Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 59: East Asia Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2017 to 2021
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2022 to 2027
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2022 to 2027
Table 76: MEA Market Value (US$ Mn) Analysis, by Technique, 2017 to 2021
Table 77: MEA Market Value (US$ Mn) Analysis, by Technique, 2022 to 2027
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Technique, 2022 to 2027
Table 79: MEA Market Value (US$ Mn) Analysis, by Organ Type, 2017 to 2021
Table 80: MEA Market Value (US$ Mn) Analysis, by Organ Type, 2022 to 2027
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Organ Type, 2022 to 2027
Table 82: MEA Market Value (US$ Mn) Analysis, by End User, 2017 to 2021
Table 83: MEA Market Value (US$ Mn) Analysis, by End User, 2022 to 2027
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by End User, 2022 to 2027
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 04: Global Market Incremental $ Opportunity, 2022 to 2027
Figure 05: Global Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 06: Global Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 07: Global Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 08: Global Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 09: Global Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 10: Global Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 11: Global Market Share and BPS Analysis by End User, 2022 & 2027
Figure 12: Global Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 13: Global Market Attractiveness Analysis by End User, 2022 to 2027
Figure 14: Global Market Share and BPS Analysis by Region, 2022 & 2027
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2022 to 2027
Figure 16: Global Market Attractiveness Analysis by Region, 2022 to 2027
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2022 to 2027
Figure 20: North America Market Incremental $ Opportunity, 2022 to 2027
Figure 21: North America Market Share Analysis by Country, 2022 & 2027
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 23: North America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 24: North America Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 25: North America Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 26: North America Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 27: North America Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 28: North America Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 29: North America Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 30: North America Market Share and BPS Analysis by End User, 2022 & 2027
Figure 31: North America Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 32: North America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 36: Latin America Market Incremental $ Opportunity, 2022 to 2027
Figure 37: Latin America Market Share Analysis by Country, 2022 & 2027
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 39: Latin America Market Attractiveness Analysis by Country, 2022 to 2027
Figure 40: Latin America Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 41: Latin America Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 42: Latin America Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 43: Latin America Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 44: Latin America Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 45: Latin America Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 46: Latin America Market Share and BPS Analysis by End User, 2022 & 2027
Figure 47: Latin America Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 48: Latin America Market Attractiveness Analysis by End User, 2022 to 2027
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 52: Europe Market Incremental $ Opportunity, 2022 to 2027
Figure 53: Europe Market Share Analysis by Country, 2022 & 2027
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 55: Europe Market Attractiveness Analysis by Country, 2022 to 2027
Figure 56: Europe Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 57: Europe Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 58: Europe Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 59: Europe Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 60: Europe Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 61: Europe Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 62: Europe Market Share and BPS Analysis by End User, 2022 & 2027
Figure 63: Europe Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 64: Europe Market Attractiveness Analysis by End User, 2022 to 2027
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 68: East Asia Market Incremental $ Opportunity, 2022 to 2027
Figure 69: East Asia Market Share Analysis by Country, 2022 & 2027
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 71: East Asia Market Attractiveness Analysis by Country, 2022 to 2027
Figure 72: East Asia Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 73: East Asia Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 74: East Asia Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 75: East Asia Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 76: East Asia Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 77: East Asia Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 78: East Asia Market Share and BPS Analysis by End User, 2022 & 2027
Figure 79: East Asia Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 80: East Asia Market Attractiveness Analysis by End User, 2022 to 2027
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2022 to 2027
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2022 & 2027
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2022 to 2027
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 94: South Asia & Oceania Market Share and BPS Analysis by End User, 2022 & 2027
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 96: South Asia & Oceania Market Attractiveness Analysis by End User, 2022 to 2027
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2017 to 2021
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2022 to 2027
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2017 to 2027
Figure 100: MEA Market Incremental $ Opportunity, 2022 to 2027
Figure 101: MEA Market Share Analysis by Country, 2022 & 2027
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2022 to 2027
Figure 103: MEA Market Attractiveness Analysis by Country, 2022 to 2027
Figure 104: MEA Market Share and BPS Analysis by Technique, 2022 & 2027
Figure 105: MEA Market Y-o-Y Growth Projections by Technique, 2022 to 2027
Figure 106: MEA Market Attractiveness Analysis by Technique, 2022 to 2027
Figure 107: MEA Market Share and BPS Analysis by Organ Type, 2022 & 2027
Figure 108: MEA Market Y-o-Y Growth Projections by Organ Type, 2022 to 2027
Figure 109: MEA Market Attractiveness Analysis by Organ Type, 2022 to 2027
Figure 110: MEA Market Share and BPS Analysis by End User, 2022 & 2027
Figure 111: MEA Market Y-o-Y Growth Projections by End User, 2022 to 2027
Figure 112: MEA Market Attractiveness Analysis by End User, 2022 to 2027
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the organ preservation solutions market?
At present, the organ preservation solutions market is valued at US$ 233 million.
What is the expected growth rate of the market?
Demand for organ preservation solutions is predicted to increase at 7.2% CAGR from 2022 to 2027.
What is the predicted market worth for organ preservation solutions?
The organ preservation solutions market is estimated to reach US$ 330 million by 2027.
What are the key driving factors for the growth of the organ preservation solutions market?
The market for organ preservation solutions is driven by a rise in organ transplantation, aging population, and technological advancements.
Who are the top industry players in the global organ preservation solutions market?
BioLife Solutions, Inc., Essential Pharmaceuticals, LLC, and Lifeline Scientific, Inc. are key players in the market.
Organ Preservation Solutions Market